About Temple syndrome due to paternal 14q32.2 microdeletion
Temple syndrome due to paternal 14q32.2 microdeletion is a rare disease catalogued by Orphanet (ORPHA:254525). It is associated with the MEG3, DLK1, RTL1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Temple syndrome due to paternal 14q32.2 microdeletion trials.
Search ClinicalTrials.gov for "Temple syndrome due to paternal 14q32.2 microdeletion" or filter by Orphanet code ORPHA:254525 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Temple syndrome due to paternal 14q32.2 microdeletion trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Temple syndrome due to paternal 14q32.2 microdeletion. Updated daily.